Trademark: 97316764
Word
QIKOVRIX
Status
Dead
Status Code
604
Status Date
Thursday, June 1, 2023
Serial Number
97316764
Mark Type
4000
Filing Date
Thursday, March 17, 2022
Published for Opposition
Tuesday, January 31, 2023
Abandoned Date
Thursday, June 1, 2023

Trademark Owner History
GlaxoSmithKline Biologicals SA - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Jun 1, 2023
Abandonment Notice E-Mailed - Inter Partes Decision
Jun 1, 2023
Abandonment - After Inter Partes Decision
Jun 1, 2023
Opposition Terminated No. 999999
Jun 1, 2023
Opposition Sustained No. 999999
Mar 2, 2023
Opposition Instituted No. 999999
Mar 2, 2023
Opposition Papers Received At Ttab
Jan 31, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 31, 2023
Published For Opposition
Jan 11, 2023
Notification Of Notice Of Publication E-Mailed
Dec 29, 2022
Approved For Pub - Principal Register
Dec 27, 2022
Assigned To Examiner
Aug 3, 2022
Teas Change Of Correspondence Received
Aug 3, 2022
Teas Change Of Domestic Representatives Address
Aug 3, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 3, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 22, 2022
New Application Office Supplied Data Entered
Mar 21, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24